Drugs Made IN America Acquisition Corp. Rights (DMAAR)
Drugs Made IN America Acquisition Corp. Rights (DMAAR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DMAAR | ||||
| Company | Drugs Made IN America Acquisition Corp. Rights | ||||
| Price Information | |||||
| Exchange | NASDAQ | ||||
| Open | 0.1202 | ||||
| High | 0.1202 | ||||
| Low | 0.1010 | ||||
| Latest | 0.1010 | ||||
| Change | -0.0090 | ||||
| % Change | -8.18% | ||||
| Volume | 1,700 | ||||
| 20-Day Average Volume | 50,975 | ||||
| Previous Close | 0.1100 | ||||
| Industry | N/A | ||||
| Has Options | No | ||||
| Technicals | |||||
| 20-Day Moving Average | 0.1196 | ||||
| 20-Day Raw Stochastic | 0.00% | ||||
| 20-Day Relative Strength | 46.92 | ||||
| Weighted Alpha | -66.76 | ||||
| Today's Opinion | 40% Sell | ||||
| Previous Opinion | 24% Sell | ||||
| Last Month's Opinion | 24% Sell | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | -15.76% since 06/02/26 | ||||
| Low | 0.1010 on 06/09/26 | ||||
| High | 0.1202 on 06/09/26 | ||||
| 1-Month | |||||
| %Chg | -27.86% since 05/08/26 | ||||
| Low | 0.1010 on 06/09/26 | ||||
| High | 0.1486 on 05/11/26 | ||||
| 3-Month | |||||
| %Chg | +54.43% since 03/09/26 | ||||
| Low | 0.0400 on 03/24/26 | ||||
| High | 0.1500 on 05/07/26 | ||||
| 6-Month | |||||
| %Chg | -43.26% since 12/09/25 | ||||
| Low | 0.0400 on 03/24/26 | ||||
| High | 0.2000 on 12/10/25 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | N/A | ||||
| Shares Outstanding, K | N/A | ||||
| Annual Sales | 0 | ||||
| Annual Net Income | 0 | ||||
| Last Quarter Sales | N/A | ||||
| Last Quarter Net Income | N/A | ||||
| 60-Month Beta | N/A | ||||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | ||||
| Earnings Date | N/A | ||||
| Most Recent Dividend | N/A | ||||
| Next Ex-Dividends Date | N/A | ||||
| Ratios | |||||
| Price/Earnings ttm | N/A | ||||